Immunizations used to treat COVID-19, respiratory syncytial virus (RSV) and influenza safely reduce the risk of adverse outcomes among people of all ages, according to a systematic analysis of 511 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback